Differential human serum-mediated neutralization of PERV released from pig cells transfected with variants of hDAF

Xenotransplantation

Volumn 15, Issue 6, 2008, Pages 365-373

  Okura, Eiji ^a   Ishimaru, Aiko ^a   Yamamoto, Aki ^a   Nakatsu, Shino ^a   Shirakura, Ryota ^a   Okabe, Masaru ^b   Sawa, Yoshiki ^a   Fukuzawa, Masahiro ^a   Okumura, Meinoshin ^a   Miyagawa, Shuji ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Complement regulatory protein; PI anchor; Porcine endogenous retroviruses; Raft; Transmembrane

Indexed keywords

BETA GALACTOSIDASE; BLOCKING ANTIBODY; COMPLEMENTARY DNA; DECAY ACCELERATING FACTOR; REGULATOR PROTEIN; SUCROSE;

ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; DNA MODIFICATION; ENDOGENOUS RETROVIRUS; ENDOTHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INCUBATION TIME; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERUM; SWINE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; ANTIGENS, CD55; CELL LINE; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; RETROVIRIDAE; SERUM; SWINE; TRANSFECTION;

EID: 58149085332     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2008.00496.x     Document Type: Article

References (37)

1. Cooper DK. Clinical Xenotransplantation - how close are we? Lancet 2003 362 : 557.
2. Miyagawa S, Hirose H, Shirakura R et al. The mechanism of discordant xenograft rejection. Transplantation 1988 46 : 825.
3. Matsunami K, Miyagawa S, Nakawagawa K, Otsuka H, Shirakura R. Molecular cloning of pig GnT-I and I.2: an application to xenotransplantation. Biochem Biophys Res Commun 2006 343 : 677.
4. Miyagawa S, Shirakura R, Iwata K et al. Effects of transfected complement regulatory proteins, MCP, DAF, and MCP/DAF hybrid, on complement-mediated swine endothelial cell lysis. Transplantation 1994 58 : 834.
5. Dai Y, Vaught TD, Boone J et al. Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol 2002 20 : 251.
6. Takahagi Y, Fujimura T, Miyagawa S et al. Production of alpha1,3-galactosyltransferase gene knockout pigs expressing both human decay-accelerating factor and N-acetylglucosaminyltransferase III. Mol Reprod Dev 2005 71 : 331.
7. Cozzi EG, Langford A, Wright L et al. Comparative analysis of human DAF expression in the tissues of transgenic pigs and man. Transplant Proc 1995 27 : 319.
8. Murakami H, Nagashima H, Takahagi Y et al. Transgenic pigs expressing human decay-accelerating factor regulated by porcine MCP gene promoter. Mol Reprod Dev 2002 61 : 302.
9. Oldmixon BA, Wood JC, Ericsson TA et al. Porcine endogenous retrovirus transmission characteristics of an inbred herd of miniature swine. J Virol 2002 76 : 3045.
10. Blusch JH, Patience C, Martin U. Pig endogenous retroviruses and xenotransplantation. Xenotransplantation 2002 9 : 242.
11. Patience C, Takeuchi Y, Weiss RA. Infection of human cells by an endogenous retrovirus of pigs. Nature Med 1997 3 : 282.
12. Wilson CA, Wong S, Muller J et al. Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells. J Virol 1998 72 : 3082.
13. Ericsson TA, Takeuchi Y, Templin C et al. Identification of receptors for pig endogenous retrovirus. Proc Natl Acad Sci U S A 2003 100 : 675.
14. Martina Y, Marcucci KT, Cherqui S et al. Mice transgenic for a human porcine endogenous retrovirus receptor are susceptible to productive viral infection. J Virol 2006 80 : 3135.
15. Paradis K, Langford G, Long Z et al. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue, The XEN 111 Study Group. Science 1998 285 : 1236.
16. Fishman JA, Patience C. Xenotransplantation: infectious risk revisited. Am J Transplant 2004 4 : 1383.
17. Takefman DM, Spear GT, Saifuddin M, Wilson CA. Human CD59 incorporation into porcine endogenous retrovirus particles: implications for the use of transgenic pigs for xenotransplantation. J Virol 2002 76 : 1999.
18. Magre S, Takeuchi Y, Langford G et al. Reduced sensitivity to human serum inactivation of enveloped viruses produced by pig cells transgenic for human CD55 or deficient for the galactosyl-alpha (1-3) galactosyl epitope. J Virol 2004 78 : 5812.
19. Hazama K, Miyagawa S, Yamamoto A et al. The effect of complement regulatory protein expression on pig endothelial cells to porcine endogenous retrovirus lyses by human sera. Transplant Proc 2005 37 : 503.
20. Ishitani A, Geraghty DE. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci U S A 1992 89 : 3947.
21. Takeda M, Leser GP, Russell CJ, Lamb RA. Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion. Proc Natl Acad Sci U S A 2003 100 : 14610.
22. Miyagawa S, Ikawa M, Kominami K et al. Difference of expression levels between gene technological product DCYT-MCP(CD46) and intact MCP(CD46) in transgenic mice. Transplant Proc 1996 28 : 585.
23. Miyagawa S, Mikata S, Tanaka H et al. The regulation of membrane cofactor protein (CD46) expression by the 3′untranslated region in transgenic mice. Biochem Biophys Res Commun 1997 233 : 829.
24. Kuttner-Kondo LA, Mitchell L, Hourcade DE, Medof ME. Characterization of the active sites in decay-accelerating factor. J Immunol 2001 167 : 2164.
25. Miyagawa S, Kubo T, Matsunami K et al. Delta-short consensus repeat 4-decay accelerating factor (DAF: CD55) inhibits complement-mediated cytolysis but not NK cell-mediated cytolysis. J Immunol 2004 173 : 3945.
26. Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991 108 : 193.
27. Kurihara T, Miyazawa T, Miyagawa S et al. Sensitivity to human serum of gammaretroviruses produced from pig endothelial cells transduced with glycosyltransferase genes. Xenotransplantation 2003 10 : 562.
28. Hazama K, Miyagawa S, Miyazawa T et al. The significance of N-linked glycosylation in pig endogenous retrovirus infectivity. Biochem Biophys Res Commun 2003 310 : 327 333.
29. Spear GT, Lurain NS, Parker CJ et al. Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV). J Immunol 1995 155 : 4376.
30. Saifuddin M, Hedayati T, Atkinson JP et al. Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction. J Gen Virol 1997 78 : 1907.
31. Saifuddin M, Parker CJ, Peeples ME et al. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1. J Exp Med 1995 182 : 501.
32. Ono A, Freed EO. Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc Natl Acad Sci U S A 2001 98 : 13925.
33. Chazal N, Gerlier D. Virus entry, assembly, budding, and membrane rafts. Microbiol Mol Biol Rev 2003 67 : 226.
34. Nayak DP, Hui EK, Barman S. Assembly and budding of influenza virus. Virus Res 2004 106 : 147.
35. Barman S, Adhikary L, Chakrabarti AK et al. Role of transmembrane domain and cytoplasmic tail amino acid sequences of influenza a virus neuraminidase in raft association and virus budding. J Virol 2004 78 : 5258.
36. Comiskey M, Goldstein CY, De Fazio SR et al. Evidence that HLA-G is the functional al homolog of mouse Qa-2, the Ped gene product. Hum Immunol 2003 64 : 999.
37. Vogt AB, Spindeldreher S, Kropshofer H. Clustering of MHC-peptide complexes prior to their engagement in the immunological synapse: lipid raft and tetraspan microdomains. Immunol Rev 2002 189 : 136.